Health Affairs, 26, no. 6 (2007): 1735-1744 doi: 10.1377/hlthaff.26.6.1735 © 2007 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Figures Only Full Text (HTML) Reprint (PDF) Technical Appendix Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Lichtenberg, F. R. Articles by Sun, S. X. Search for Related Content PubMed PubMed Citation Articles by Lichtenberg, F. R. Articles by Sun, S. X. Related Collections Health Reform Managed Care - Medicare Medicare Pharmaceuticals Chronic Care Health Spending Consumer Issues Elderly

DataWatch

The Impact Of Medicare Part D On Prescription Drug Use By The Elderly

This study investigates the effect of Medicare Part D on the elderly’s prescription drug use and out-of-pocket costs using a difference-in-differences research design. We estimate that Medicare Part D reduced user cost among the elderly by 18.4 percent, increased their use of prescription drugs by about 12.8 percent, and increased total U.S. usage by 4.5 percent in 2006. The estimated crowd-out rate was about 72 percent: Every seven prescriptions paid for by the government crowded out five other prescriptions and resulted in only two additional prescriptions used. This does not necessarily mean that Medicare Part D is an economically inefficient program.

                      What's this?

This article has been cited by other articles:

				P. Neuman and J. Cubanski Medicare Part D Update -- Lessons Learned and Unfinished Business N. Engl. J. Med., July 23, 2009; 361(4): 406 - 414. [Full Text] [PDF]

				S. Schneeweiss, A. R. Patrick, A. Pedan, L. Varasteh, R. Levin, N. Liu, and W. H. Shrank The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits Health Aff., March 1, 2009; 28(2): w305 - w316. [Abstract] [Full Text] [PDF]

				J. M. Hoffman, N. D. Shah, L. C. Vermeulen, F. Doloresco, P. K. Martin, S. Blake, L. Matusiak, R. J. Hunkler, and G. T. Schumock Projecting future drug expenditures--2009 Am. J. Health Syst. Pharm., February 1, 2009; 66(3): 237 - 257. [Abstract] [Full Text] [PDF]

				D. N. Lakdawalla, D. P. Goldman, P.-C. Michaud, N. Sood, R. Lempert, Z. Cong, H. de Vries, and I. Gutierrez U.S. Pharmaceutical Policy In A Global Marketplace Health Aff., January 1, 2009; 28(1): w138 - w150. [Abstract] [Full Text] [PDF]

				H. Chen, A. Nwangwu, R. Aparasu, E. Essien, S. Sun, and K. Lee The Impact of Medicare Part D on Psychotropic Utilization and Financial Burden for Community-Based Seniors Psychiatr Serv, October 1, 2008; 59(10): 1191 - 1197. [Abstract] [Full Text] [PDF]

				J. Hsu, V. Fung, M. Price, J. Huang, R. Brand, R. Hui, B. Fireman, and J. P. Newhouse Medicare Beneficiaries' Knowledge of Part D Prescription Drug Program Benefits and Responses to Drug Costs JAMA, April 23, 2008; 299(16): 1929 - 1936. [Abstract] [Full Text] [PDF]

				W. Yin, A. Basu, J. X. Zhang, A. Rabbani, D. O. Meltzer, and G. C. Alexander The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures Ann Intern Med, February 5, 2008; 148(3): 169 - 177. [Abstract] [Full Text] [PDF]

				B. Stuart Where Are the Medicare Part D Claims Data? Ann Intern Med, February 5, 2008; 148(3): 239 - 240. [Full Text] [PDF]